Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (1): 152-157.doi: 10.13481/j.1671-587x.20210121
• Research in basic medicine • Previous Articles Next Articles
Guanhu LI1,Qingxu LANG1,Chunyan LIU2,Qin LIU1,Mengrou GENG1,Xiaoqian LI1,Zhenqi WANG1(
)
Received:2020-01-19
Online:2021-01-28
Published:2021-01-27
Contact:
Zhenqi WANG
E-mail:wangzq@jlu.edu.cn
CLC Number:
Guanhu LI,Qingxu LANG,Chunyan LIU,Qin LIU,Mengrou GENG,Xiaoqian LI,Zhenqi WANG. Inhibitory effect of sodium butyrate combined with X- irradiation on proliferation of lung cancer A549 cells and its influence in cell cycle[J].Journal of Jilin University(Medicine Edition), 2021, 47(1): 152-157.
Tab.1
Proliferation rates of A549 cells in various groups 24, 48 and 72 h after treated with different concentrations of NaBt alone or combined with 4 Gy X-irradiation (n=8,x±s,η/%)"
| Group | Proliferation rate | ||
|---|---|---|---|
| (t/h) 24 | 48 | 72 | |
| Control | 1.00±0.00 | 1.00±0.00 | 1.00±0.00 |
| NaBt (mmol·L-1) | |||
| 5 | 0.95±0.33 | 0.95±0.01** | 0.61±0.01** |
| 10 | 0.98±0.32 | 0.98±0.01 | 0.51±0.04** |
| 15 | 0.98±0.28 | 0.96±0.01* | 0.58±0.02** |
| 20 | 1.00±0.03 | 0.95±0.01** | 0.62±0.01** |
| 25 | 0.96±0.04 | 0.91±0.02** | 0.53±0.03** |
| 4 Gy X-ray irradiation | 1.02±0.01 | 0.98±0.01 | 0.96±0.05 |
| NaBt+4 Gy X-ray irradiation | |||
| 5 mmol·L-1+4 Gy | 1.06±0.02* | 0.99±0.03 | 0.61±0.03**## |
| 10 mmol·L-1+4 Gy | 1.15±0.06* | 0.99±0.04 | 0.53±0.04**## |
| 15 mmol·L-1+4 Gy | 1.08±0.01** | 0.91±0.02**△## | 0.55±0.03**## |
| 20 mmol·L-1+4 Gy | 1.06±0.02** | 0.91±0.02**△# | 0.49±0.01**△△## |
| 25 mmol·L-1+4 Gy | 1.02±0.01 | 0.89±0.01**△## | 0.39±0.02**△△## |
Tab.2
Percentages of A549 cells in different cell cycles in various groups 24 h after treated with different concentrations of NaBt alone or combined with 4 Gy X-ray irradiation (n=3,x±s,η/%)"
| Group | Percentage of A549 cells | ||
|---|---|---|---|
| G0/G1 | G2 + M | S | |
| Control | 83.057 ± 0.071 | 2.060 ± 0.839 | 14.883±0.783 |
NaBt (mmol·L-1) 10 | 93.203±0.482** | 3.923±0.245 | 2.873±0.062** |
| 20 | 88.890±0.538** | 7.287±0.345* | 3.823±0.049** |
| 4 Gy X-ray irradiation | 69.103±0.501** | 27.490±0.540** | 3.403±0.057** |
| 10 mmol·L-1 NaBt +4 Gy X-ray irradiation | 64.133±0.904** | 32.593±0.952** | 3.270±0.162** |
| 20 mmol·L-1 NaBt +4 Gy X-ray irradiation | — | — | — |
| 1 | 马书梅, 刘瑞娟, 张影影. 肺癌的流行病学[J]. 世界最新医学信息文摘, 2019, 19(26): 77-78, 80. |
| 2 | YASMIN R, SIRAJ S, HASSAN A, et al. Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies [J]. Mediators Inflamm, 2015, 2015:201703. |
| 3 | SETO E, YOSHIDA M. Erasers of histone acetylation: the histone deacetylase enzymes [J]. Cold Spring Harb Perspect Biol, 2014, 6(4): a018713. |
| 4 | OKUDELA K, MITSUI H, SUZUKI T, et al. Expression of HDAC9 in lung cancer:potential role in lung carcinogenesis [J]. Int J Clin Exp Pathol, 2014, 7(1): 213-220. |
| 5 | FALKENBERG K J, JOHNSTONE R W. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders [J]. Nat Rev Drug Discov, 2014, 13(9): 673-691. |
| 6 | SURAWEERA A, O’BYRNE K J, RICHARD D J, et al. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi [J]. Front Oncol, 2018, 8:92. |
| 7 | MCMILLAN M T, OJERHOLM E, VERMA V, et al. Radiation treatment time and overall survival in locally advanced non-small cell lung cancer [J]. Int J Radiat Oncol Biol Phys, 2017, 98(5): 1142-1152. |
| 8 | HESSMANN E, JOHNSEN S A, SIVEKE J T, et al. Epigenetic treatment of pancreatic cancer: Is there a therapeutic perspective on the horizon? [J]. Gut, 2017, 66(1):168-179. |
| 9 | BAO L M,DIAO H,DONG N, et al. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation [J]. Cell Biol Toxicol, 2016, 32(6): 469-482. |
| 10 | FISCHER C, LEITHNER K, WOHLKOENIG C, et al. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization [J]. Mol Cancer, 2015, 14: 4. |
| 11 | TO K K, TONG W S, FU L W. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat [J]. Lung Cancer, 2017, 103: 58-65. |
| 12 | MINAMIYA Y, ONO T, SAITO H, et al. Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung[J]. Lung Cancer, 2011, 74(2): 300-304. |
| 13 | OSADA H, TATEMATSU Y, SAITO H, et al. Reduced expression of class Ⅱ histone deacetylase genes is associated with poor prognosis in lung cancer patients [J]. Int J Cancer, 2004, 112(1): 26-32. |
| 14 | ZHANG Q C, JIANG S J, ZHANG S, et al. Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line [J]. Asian Pac J Cancer Prev, 2012, 13(7): 3471-3476. |
| 15 | GROSELJ B, SHARMA N L, HAMDY F C, et al. Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair [J]. Br J Cancer, 2013, 108(4): 748-754. |
| 16 | ADIMOOLAM S, SIRISAWAD M, CHEN J, et al. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination [J]. Procl Natl Acad Sci USA, 2007, 104 (49): 19482-19487. |
| 17 | MCMILLAN M T, OJERHOLM E, VERMA V, et al. Radiation treatment time and overall survival in locally advanced non-small cell lung cancer [J]. Int J Radiat Oncol Biol Phys, 2017, 98(5): 1142-1152. |
| 18 | JIN X F, WU N N, DAI J J, et al. TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4-phenylbutyrate treatment [J]. Cancer Med,2017, 6(2): 424-438. |
| 19 | LI L, SUN Y, LIU J, et al. Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells [J]. BMC Biochem, 2015, 16(1): 2. |
| 20 | BOURKE E, BROWN J A,TAKEDA S, et al. DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2 [J]. Oncogene, 2010, 29(4): 616-624. |
| 21 | 敖经盛, 鲍志荣, 全 红. 纳米复合材料GO@AgPt对非小细胞肺癌的放射增敏作用[J].中国医学物理学杂志,2020,37(4): 514-519. |
| 22 | TAILOR D,HAHM E R,KALE R K, et al. Sodium butyrate induces DRP1-mediated mitochondrial fusion and apoptosis in human colorectal cancer cells [J]. Mitochondrian, 2014, 16: 55-64. |
| 23 | MAHA S A, KAREM H A, SAIED A J, et al. The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells [J]. Clin Pharmacol, 2018,10: 135-140. |
| 24 | RIVERA S,LETEUR C,MEGNIN F, et al. Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat [J]. Oncotarget, 2017, 8(34): 56210-56227. |
| [1] | Yi LONG,Ziyi YOU,Xiuying TAN,Rou ZHANG,Yuhan ZHANG,Lina YANG. Protective effect of sodium butyrate on acute liver injury in mice induced by lipopolysaccharide combined with D-galactosamine and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1614-1620. |
| [2] | Yi XIE,Yang LIU,Hongyan LI,Xiaowei XU. Research progress in effect of histone acetylation modifications on occurrence and development of periodontitis [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1457-1464. |
| [3] | Qingxu LANG,Xueshuang NIU,Kaiwen YANG,Ren ZHANG,Siteng WANG, ZUMIRETIGULI·Wumaier,Zhenqi WANG. Effects of sodium butyrate combined with ionizing radiation on apoptosis of lung cancer A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 915-921. |
| [4] | Guanhu LI,Qingxu LANG,Chunyan LIU,Qin LIU,Mengrou GENG,Xiaoqian LI,Zhenqi WANG. Inhibitory effect of valproic acid combined with X-ray irradiation on proliferation of breast cancer MDA-MB-231 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 622-629. |
| [5] | Yihan WANG,Yidan WANG,Hetong HUI,Xinyuan FAN,Tianqi WANG,Wei XIA,Limei LIU. Detection of promoter methylation levels of Wnt5A and LINE-1 in serum during extramedullary infiltration in acute lymphoblastic leukemia transplanted tumor model mice and its significance [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 284-290. |
| [6] | XIN Rui, LI Dong, XU Huiying, WANG Chunyu, QU Danhua, SUN Haifeng. Influence of miRNA-21 in radiosensitivity of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 772-778. |
| [7] | YANG Wenyan, LIU Qiang, SUN Zhijuan, DU Liqing, XU Chang, WANG Yan, LIU Yang, WANG Qin. Effect of melatonin on radiosensitivity of non-small cell lung cancer H1299 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 532-536. |
| [8] | TU Peipei, LI Xiaodan, MA Baicheng, ZHANG Yaofang, DUAN Huikun, NI Zaizhong, WANG Haisong, JIANG Pingzhe, LI Miao, WU Ri, LI Minggang. Changes and significance of hepatic histone H3 epigenetic modification in type 2 diabetic mice [J]. Journal of Jilin University Medicine Edition, 2015, 41(04): 756-762. |
| [9] | YANG Yan-ming,FANG Fang,LIU Nian,QU Zhi-jie,WANG Zhi-cheng,ZHANG Yan-qiu. Influence of pEgr1-hsTRAL plasmid on radiosensitivity and DR4 and DR5 expression levels in lung adenocarcinoma A549 cells [J]. Journal of Jilin University Medicine Edition, 2013, 39(2): 199-203. |
| [10] |
LIANG Bing,LIU Xiao-dong,XU Hui-ying,XIN Rui,KONG De-juan,HE Meng-zi,JIA Li-li,.
Effects of deoxycytidine kinase on sensitivity to radiotherapy and chemotherapy in HeLa cells [J]. J4, 2012, 38(2): 197-201. |
| [11] | ZHAO Tong, WANG Xiu-Lan, LIU Yong, WANG Ruo-Yu. Radiosensitization of epithelial growth factor receptor monoclonal antibody on lung adenocarcinoma cell line SPC-A-1 [J]. J4, 2011, 37(3): 483-486. |
| [12] | SUN Bao-sheng,LIU Shi-xin,WANG Tie-jun,HUANG Guo-min,GONG Shou-liang,LIU Lin-lin. Effects of taurolidine on radiosensitivity of murine melanoma cells and its mechanism [J]. J4, 2008, 34(6): 923-926. |
| [13] | DI Qian, LI Yang, ZHAO Xue-jian, MIYAGI Taeko. Effects of sodium butyrate on cell growth inhibitionand apoptosis in PC-3M cell lines [J]. J4, 2004, 30(5): 710-712. |